» Articles » PMID: 39135654

Effect of Chemotherapeutic Agents on Natural Transformation Frequency in Acinetobacter Baylyi

Overview
Specialty Microbiology
Date 2024 Aug 13
PMID 39135654
Authors
Affiliations
Soon will be listed here.
Abstract

Natural transformation is the ability of a bacterial cell to take up extracellular DNA which is subsequently available for recombination into the chromosome (or maintenance as an extrachromosomal element). Like other mechanisms of horizontal gene transfer, natural transformation is a significant driver for the dissemination of antimicrobial resistance. Recent studies have shown that many pharmaceutical compounds such as antidepressants and anti-inflammatory drugs can upregulate transformation frequency in the model species . Chemotherapeutic compounds have been shown to increase the abundance of antimicrobial resistance genes and increase colonization rates of potentially pathogenic bacteria in patient gastrointestinal tracts, indicating an increased risk of infection and providing a pool of pathogenicity or resistance genes for transformable commensal bacteria. We here test for the effect of six cancer chemotherapeutic compounds on natural transformation frequency, finding two compounds, docetaxel and daunorubicin, to significantly decrease transformation frequency, and daunorubicin to also decrease growth rate significantly. Enhancing our understanding of the effect of chemotherapeutic compounds on the frequency of natural transformation could aid in preventing the horizontal spread of antimicrobial resistance genes.

References
1.
de Kogel C, Schellens J . Imatinib. Oncologist. 2008; 12(12):1390-4. DOI: 10.1634/theoncologist.12-12-1390. View

2.
Winter M, Buckling A, Harms K, Johnsen P, Vos M . Antimicrobial resistance acquisition via natural transformation: context is everything. Curr Opin Microbiol. 2021; 64:133-138. DOI: 10.1016/j.mib.2021.09.009. View

3.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

4.
Slevin M, Piall E, Aherne G, Harvey V, Johnston A, Lister T . Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol. 1983; 1(9):546-51. DOI: 10.1200/JCO.1983.1.9.546. View

5.
Morgan C, Lewis P, Jones R, Bertelli G, Thomas G, Leonard R . The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer. Acta Oncol. 2007; 46(5):669-77. DOI: 10.1080/02841860600996447. View